Researchers Find Assay for Drugs Targeting Prostate Cancer
New high-throughput screening assay is designed to identify inhibitors of the androgen receptor, which plays a vital role in the progression of prostate cancer.
Source: medindia.net
Stay updated with breaking news from Drug Development Technologies. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
New high-throughput screening assay is designed to identify inhibitors of the androgen receptor, which plays a vital role in the progression of prostate cancer.
A novel high-throughput screening assay is designed to identify inhibitors of the androgen receptor, which plays a critical role in the progression of prostate cancer.
· New milestone for NeuroLead, the active agent screening platform · New publications in scientific journals · Start of Phase I/II clinical trial for Batten disease Lyon, 28 February 2022 -